ArticleReproductive toxicology (Elmsford, N.Y.)2026
Longitudinal patterns of urinary biomarkers of placental and renal function in pregnancy and associations with early pregnancy exposure to phthalates and replacements.
Article in Reproductive toxicology (Elmsford, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Phthalates and replacements are endocrine-disrupting chemicals that may interfere with early pregnancy processes such as placentation and renal adaptation. Placental and renal biomarkers may help examine these toxicologic mechanisms. This study aims to characterize longitudinal changes in urinary protein biomarkers of placental angiogenesis (sFlt-1, PlGF, sEng) and renal function (KIM-1, NGAL, nephrin), and investigate associations with early pregnancy exposure to phthalates and replacements. Among 291 participants from the Human Placenta and Phthalates prospective cohort, urinary metabolites of eight phthalates and two replacements were quantified at up to 2 time points from 12 to 15 weeks gestation. Repeated measures were averaged as early pregnancy exposure biomarkers. Placental and renal biomarkers were quantified longitudinally in urine samples from early (median 13 weeks), middle (21 weeks), and late (33 weeks) pregnancy. Linear mixed effects models with participant-specific random effects estimated the percent change in placental or renal biomarker concentrations throughout pregnancy in association with a one interquartile range increase in early pregnancy phthalate and replacement biomarkers. Certain protein biomarkers showed trends across gestation (sFlt-1, PlGF, NGAL), while others did not (sEng, KIM-1, nephrin). Early pregnancy mono-3-carboxypropyl phthalate was associated with decreased urinary concentrations of NGAL (-6.66% [95% confidence interval: -12.23%, -0.74%]), but this association was nonsignificant after multiple comparisons correction. Associations between other phthalate and replacement biomarkers with placental and renal proteins were imprecise. Urinary biomarkers of placental angiogenesis and renal function change dynamically in pregnancy; further research is needed to validate associations between urinary proteins and phthalate metabolites, and to explore additional toxicity mechanisms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.